Truist Cuts PT on Viridian Therapeutics (VRDN) to $36 From $40
Summary
Viridian Therapeutics, Inc. (NASDAQ:VRDN) is one of the most oversold healthcare stocks to invest in. Truist cut the price target on Viridian Therapeutics, Inc.
Description
Viridian Therapeutics, Inc. (NASDAQ:VRDN) is one of the most oversold healthcare stocks to invest in. Truist cut the price target on Viridian Therapeutics, Inc.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source